Last reviewed · How we verify
Progesterone Vaginal Gel 8% — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Progesterone Vaginal Gel 8% (Progesterone Vaginal Gel 8%) — Eastern Virginia Medical School.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Progesterone Vaginal Gel 8% TARGET | Progesterone Vaginal Gel 8% | Eastern Virginia Medical School | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Progesterone Vaginal Gel 8% CI watch — RSS
- Progesterone Vaginal Gel 8% CI watch — Atom
- Progesterone Vaginal Gel 8% CI watch — JSON
- Progesterone Vaginal Gel 8% alone — RSS
Cite this brief
Drug Landscape (2026). Progesterone Vaginal Gel 8% — Competitive Intelligence Brief. https://druglandscape.com/ci/progesterone-vaginal-gel-8. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab